Comparison of bleeding risk between colistin– tigecycline and colistin–carbapenem treatment regimens: A retrospective cohort study

Huang, Yu-TingYu-TingHuangYu, Chia-IChia-IYuPAO-YU CHENCHI-CHUAN WANGCHIEN-CHIH WU2022-12-292022-12-2920211178-6973https://scholars.lib.ntu.edu.tw/handle/123456789/626827Antibiotic combination is commonly used to treat multidrug-resistant pathogens. Reports have indicated that tigecycline use is associated with hypofibrinogenemia. However, whether the bleeding risk of tigecycline is higher than that of other antibiotics remains unknown. The aim of this study was to compare the bleeding risk between colistin-tigecycline and colistin-carbapenem treatment.enbleeding events; carbapenems; tigecycline[SDGs]SDG3Comparison of bleeding risk between colistin– tigecycline and colistin–carbapenem treatment regimens: A retrospective cohort studyjournal article10.2147/IDR.S339188348580352-s2.0-85120160731WOS:000723247800002https://api.elsevier.com/content/abstract/scopus_id/85120160731